Dr.Different 131 Moisturizer

Manufacturer
Dareun Cosmetics Co., Ltd. | E.CIS COSMETIC.,Co.Ltd
Effective date
2021-04-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:39:33

Label at a glance#

ProductDr.Different 131 Moisturizer
Active ingredientAdenosine
Label structure8 sections

Indications and uses

■ Helps improve wrinkle problem.

Dosage and administration

■ After cleansing, take out an adequate amount then gently apply on dry areas. Apply whenever the skin feels dry.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Adenosine 0.04%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

WATER, CAPRYLIC/CAPRIC TRIGLYCERIDE, BUTYLENE GLYCOL, GLYCERIN, PENTAERYTHRITYL TETRAISOSTEARATE, 1,2-HEXANEDIOL, GLYCERYL STEARATE SE, CETYL ALCOHOL, STEARYL ALCOHOL, CETEARYL OLIVATE, CHOLESTEROL, SORBITAN SESQUIOLEATE, OLEA EUROPAEA (OLIVE) FRUIT OIL, SORBITAN OLIVATE, HYDROXYPROPYL BISPALMITAMIDE MEA, STEARIC ACID, CARBOMER, ETHYLHEXYLGLYCERIN, MYRISTYL ALCOHOL, ARGININE, ISOMERIZED LINOLEIC ACID, LAURYL ALCOHOL, DECYLENE GLYCOL, CAPRYLYL GLYCOL, XANTHAN GUM, OLEIC ACID, PALMITIC ACID, TOCOPHEROL, MEVALONOLACTONE, HYDROGENATED PHOSPHATIDYLCHOLINE, LINOLEIC ACID, SODIUM PCA, SERINE, GLYCINE, TREMELLA FUCIFORMIS POLYSACCHARIDE, ROSA CANINA FRUIT EXTRACT, CERAMIDE NP, ALANINE, GLUTAMIC ACID, CHOLESTERYL MACADAMIATE, SUCROSE STEARATE, PHYTOS PHINGOSINE, GLYCOSPHINGOLIPIDS

PURPOSE

OTC - PURPOSE SECTION

Anti wrinkle

WARNINGS

WARNINGS SECTION

For external use only.
1. If there is any red spot, swallowing or itching by direct sunlight or if there is any other adverse effect during or after cosmetics use, consult with a doctor.
2. Refrain from using on the injured area.
3. Precaution for storage and handling.
a) Keep out of reach of children.
b) Keep away from direct sunlight.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ Helps improve wrinkle problem.

Directions

DOSAGE & ADMINISTRATION SECTION

■ After cleansing, take out an adequate amount then gently apply on dry areas. Apply whenever the skin feels dry.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ADENOSINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d676a241-be05-4740-b3ee-1a5f2ed422d2Product name420180615
dd8bd48f-20d6-43c7-b471-3ae872868afaProduct name320180125
d41954ff-bc63-4b2c-aba0-9146707659d7Product name220151117

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81710-020-022022-07-29C16284748780-1e4f33bdf-b1a4-d8a0-e053-dadaa90a6e4eecff4c46-2005-4637-b79d-91b84691e7b2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81710-020-01Dr.Different 131 Moisturizer100 mL in 1 BOTTLELIQUID1001
81710-020-02Dr.Different 131 Moisturizer1 in 1 CARTONLIQUID11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81710-020DR.DIFFERENT 131 MOISTURIZER (ADENOSINE) LIQUID [DAREUN COSMETICS CO., LTD.]1Legacy NDC, 2 package rows20210410_ecff4c46-2005-4637-b79d-91b84691e7b2.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81710-02081710-020-01, 81710-020-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ce4555a0-7f14-4b49-a08b-c38a5e017aa7ecff4c46-2005-4637-b79d-91b84691e7b22021-04-09WarningsExact identifier
spl id: ce4555a0-7f14-4b49-a08b-c38a5e017aa7
spl set id: ecff4c46-2005-4637-b79d-91b84691e7b2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.